Topic · 1 report

Patent Litigation

RegulationWatch reporting on patent litigation matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. Patent Litigation

    Pfizer settled with three generic challengers and pushed Vyndamax competition to 2031. No court ruled its patents valid.

    The settlements are private, their terms are undisclosed, and patients keep paying the branded price for up to two more years.